QurCan, Lilly Ink Research Deal For CNS, PNS Genetic Medicines

KUALA LUMPUR, Sept 17 (Bernama) -- QurCan Therapeutics (QurCan), a Toronto-based biotechnology company, has announced an exclusive research and collaboration agreement with Eli Lilly and Company (Lilly) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS).

All AirAsia Operating Crew Tested Negative For Drugs

KUALA LUMPUR, Sept 14 (Bernama) -- All active AirAsia Malaysia and AirAsia X Malaysia operating crew have tested negative for drugs following a screening exercise conducted as part of the airlines’ fit-to-fly and safety protocols.

IHH Says Fortis Acquisition Delays Caused Losses Amid Daiichi Sankyo Dispute With Debtors

KUALA LUMPUR, Sept 11 (Bernama) -- IHH Healthcare Bhd said it suffered losses due to delays in obtaining the required mandatory tender offer (MTO) approvals for its acquisition of Fortis Healthcare amid a dispute between Japanese pharmaceutical company Daiichi Sankyo Co Ltd and its “judgment debtors.”

Tokyo Court Dismisses IHH Unit’s Claims Against Daiichi Sankyo

KUALA LUMPUR, Sept 10 (Bernama) -- The Tokyo District Court has dismissed all claims brought by IHH Healthcare Bhd’s indirect wholly-owned subsidiary Northern TK Venture Pte Ltd (NTK) against Japanese pharmaceutical company Daiichi Sankyo Company Ltd.

Safety Is Non-Negotiable For MAG, Will Do Annual Drug Screening Among Crew

KUALA LUMPUR, Sept 4 (Bernama) -- Safety remains a non-negotiable priority for Malaysia Aviation Group (MAG) as it continues to strengthen its safety measures, processes and standards, its president and group chief executive officer, Captain Nasaruddin A Bakar, said. 

Curia Opens Expanded Albuquerque Manufacturing Campus 

KUALA LUMPUR, Sept 4 (Bernama) -- Curia Global Inc (Curia) has opened its expanded campus in Albuquerque, New Mexico, following a US$200 million investment to increase domestic manufacturing capacity for critical injectable medicines. (US$1=RM4.03)

Fortrea To Acquire Worldwide’s Early Phase Business

KUALA LUMPUR, Sept 3 (Bernama) -- Fortrea and Worldwide Clinical Trials (Worldwide) have signed a definitive agreement under which Fortrea will acquire Worldwide’s Early Phase Services division (Early Phase) in an all-cash transaction valued at approximately US$45 million. (US$1=RM4.03)

MAG Mandates Drug Screening For All Pilots, Says Detained Pilot Was Off Duty

KUALA LUMPUR, Aug 7 (Bernama) -- Malaysia Aviation Group (MAG) has commenced mandatory drug screening for all 1,260 Malaysia Airlines pilots and will implement stricter screening for all active pilots, going beyond current industry practice.

Digital Financial Crime Demands Smarter, Data-driven Compliance - Labuan FSA

LABUAN, Aug 4 (Bernama) -- Financial institutions must adopt more intelligent, data-driven and risk-based compliance systems as financial crimes become increasingly digital, interconnected and difficult to trace. 

CAAM To Probe Circumstances Of Malaysian Pilot's Detention In Indonesia

By Kisho Kumari Sucedaram

KUALA LUMPUR, July 31 (Bernama) -- The Civil Aviation Authority of Malaysia (CAAM) is investigating the reported detention of a Malaysian pilot in Indonesia from a regulatory perspective, including whether there were any lapses before the individual departed from Malaysia.

Malaysia Airlines Reserves Comment, Cooperates With Indonesian Authorities Over Pilot's Alleged Drug Offence

By Kisho Kumari Sucedaram

KUALA LUMPUR, July 31 (Bernama) -- Malaysia Airlines reserves its comment on its pilot being caught for a narcotics-related offence by the Indonesian authorities but noted that the airline takes such allegations seriously.

Ringgit Ends Higher Vs US Dollar, Other Currencies Amid Rising Oil Prices

By Durratul Ain Ahmad Fuad

KUALA LUMPUR, July 22 (Bernama) -- The spike in crude oil prices helped lift the ringgit, which finished higher against the US dollar and other major currencies at today's close.